Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business – GenomeWeb
The firms have agreed to transition the business to Beckman, with Quidel receiving annual payments until 2029.
recent post
-
Oct 12 2025 -
-
Oct 12 2025
-
-
Oct 12 2025
